Afrezza inhaled insulin: the fastest-acting FDA-approved insulin on the market has favorable properties (Q42723229)
Jump to navigation
Jump to search
scientific article published on November 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Afrezza inhaled insulin: the fastest-acting FDA-approved insulin on the market has favorable properties |
scientific article published on November 2014 |
Statements
1 reference
Afrezza inhaled insulin: the fastest-acting FDA-approved insulin on the market has favorable properties (English)
1 reference
David C Klonoff
1 reference
1 reference
1 reference
Identifiers
1 reference